Trial Profile
Crossover study to determine pharmacodynamic effects of Nebivolol and Valsartan, given in combination or as monotherapy in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 May 2015
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary) ; Valsartan (Primary)
- Indications Hypertension
- Focus Pharmacodynamics
- 19 May 2015 Status changed from not stated to completed.
- 04 May 2015 New trial record